![Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. - Abstract - Europe PMC Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5431585/bin/nihms849080f2.jpg)
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. - Abstract - Europe PMC
![Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis | BMC Rheumatology | Full Text Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis | BMC Rheumatology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs41927-022-00262-2/MediaObjects/41927_2022_262_Fig2_HTML.png)
Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis | BMC Rheumatology | Full Text
![Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis - Dinesh Khanna, Daniel E. Furst, Philip J. Clements, Yannick Allanore, Murray Baron, Lazlo Czirjak, Oliver Distler, Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis - Dinesh Khanna, Daniel E. Furst, Philip J. Clements, Yannick Allanore, Murray Baron, Lazlo Czirjak, Oliver Distler,](https://journals.sagepub.com/cms/10.5301/jsrd.5000231/asset/images/large/10.5301_jsrd.5000231-fig3.jpeg)
Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis - Dinesh Khanna, Daniel E. Furst, Philip J. Clements, Yannick Allanore, Murray Baron, Lazlo Czirjak, Oliver Distler,
![Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis - Dinesh Khanna, Daniel E. Furst, Philip J. Clements, Yannick Allanore, Murray Baron, Lazlo Czirjak, Oliver Distler, Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis - Dinesh Khanna, Daniel E. Furst, Philip J. Clements, Yannick Allanore, Murray Baron, Lazlo Czirjak, Oliver Distler,](https://journals.sagepub.com/cms/10.5301/jsrd.5000231/asset/images/large/10.5301_jsrd.5000231-fig4.jpeg)
Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis - Dinesh Khanna, Daniel E. Furst, Philip J. Clements, Yannick Allanore, Murray Baron, Lazlo Czirjak, Oliver Distler,
![Histologic Features Correlate with the Modified Rodnan Skin Score, Serum Inflammatory Markers, and Patient Reported Outcomes in Patients with Early, Diffuse Cutaneous Systemic Sclerosis - ACR Meeting Abstracts Histologic Features Correlate with the Modified Rodnan Skin Score, Serum Inflammatory Markers, and Patient Reported Outcomes in Patients with Early, Diffuse Cutaneous Systemic Sclerosis - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2019/08/GTUOHVCE-675971-1-ANY-3-.jpg)
Histologic Features Correlate with the Modified Rodnan Skin Score, Serum Inflammatory Markers, and Patient Reported Outcomes in Patients with Early, Diffuse Cutaneous Systemic Sclerosis - ACR Meeting Abstracts
![Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma - Low - 2019 - International Journal of Rheumatic Diseases - Wiley Online Library Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma - Low - 2019 - International Journal of Rheumatic Diseases - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ab0fba27-6a0f-4528-a96a-bf8c8b76dd32/apl13523-fig-0001-m.png)
Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma - Low - 2019 - International Journal of Rheumatic Diseases - Wiley Online Library
![Figure 2 from Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis | Semantic Scholar Figure 2 from Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6bd1d80a9de36507df11ae53546945e89f385b82/3-Figure2-1.png)
Figure 2 from Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis | Semantic Scholar
![Durometry as an alternative tool to the modified Rodnan's skin score in the assessment of diffuse systemic sclerosis patients: a cross-sectional study | Advances in Rheumatology | Full Text Durometry as an alternative tool to the modified Rodnan's skin score in the assessment of diffuse systemic sclerosis patients: a cross-sectional study | Advances in Rheumatology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs42358-020-00152-6/MediaObjects/42358_2020_152_Fig1_HTML.png)
Durometry as an alternative tool to the modified Rodnan's skin score in the assessment of diffuse systemic sclerosis patients: a cross-sectional study | Advances in Rheumatology | Full Text
![Early detection of pulmonary involvement in scleroderma patients By Mohamed Mostafa Metwally, MD, FCCP Assistant professor of chest diseases Assiut University. - ppt download Early detection of pulmonary involvement in scleroderma patients By Mohamed Mostafa Metwally, MD, FCCP Assistant professor of chest diseases Assiut University. - ppt download](https://images.slideplayer.com/19/5775688/slides/slide_8.jpg)
Early detection of pulmonary involvement in scleroderma patients By Mohamed Mostafa Metwally, MD, FCCP Assistant professor of chest diseases Assiut University. - ppt download
![Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial - The Lancet Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial - The Lancet](https://www.thelancet.com/cms/attachment/63f83086-2898-478d-97a5-aebc18eb52d0/gr4_lrg.jpg)
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial - The Lancet
![PDF] Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials. | Semantic Scholar PDF] Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/61ca662e9b493f9ac358e0592941592afede9ddb/2-Table1-1.png)
PDF] Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials. | Semantic Scholar
![Figure 3 from Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis | Semantic Scholar Figure 3 from Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6bd1d80a9de36507df11ae53546945e89f385b82/4-Figure3-1.png)